TCT-517 Endovascular Management of Massive Broncho Pulmonary Fistula – a Series of 28 Cases  by KHANNA, NARENDRAN & Rao, Suparna
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comthrombosis, collateral branch thrombosis. We used a new concept of stent, the
Multilayer Flow Modulator (MFM*) to treat An. and try to avoid some drawbacks
encountered with endografts.
Methods: This MFM* is a 3 Dimensional braided tube made of several inter-
connected layers without any covering. Our earliest in vitro (theorical simulation),
computerized Fluid dynamics, Molecular Modelization and in vivo tests demonstrated
that this MFM* reduces the velocity in the aneurismal sac up to 90% by modifying the
hemodynamic conditions. A saccular aneurysm without collateral branch will
thrombose quickly. If a collateral branch is present the ﬂow is directed towards this
branch leading to shrinkage of the aneurysm. Animal experiments show excellent
results. Moreover, as demonstrated in animal and human studies this MFM* preserves
the collateral branches allowing the possibility to cover any artery without compro-
mising the ﬂow (renal, digestive arteries, supra aortic vessels.)
Results: 44 peripheral An. (iliac:23, femoral:1, popliteal:5, renal:8, mesenteric:2, ca-
rotid: 2, Subclavian : 2, Caeliac trunk :1) were treated with the MFM* (male:31, mean
age 62+/-8 y) (57 stents ⌀ 5 to 14mm; length 40 to 120mm)were implanted to treat these
aneurysms, by femoral approach (39 cases), brachial approach (1 case), Technical
success in all patients. No complications. All An. thrombosedwith diameter reduction in
some pts. The thrombosis could take several weeks depending on the importance of
collateral branches. 6month to 36month follow upwill be presented and wewill discuss
the time needed to achieve exclusion of the An. All the side branches remained patent.
Conclusions: A new concept of stent, the MFM* (without any covering) is developed
to treat An. It opens a new approach to treat peripheral An. avoiding most of the
complications encountered with current endovascular techniques. The results obtained
seem promising. A larger study is ongoing.
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Background: Broncho –Pulmonary Fistula (BPF) occurs in 2-3 per 100, 000 popu-
lation. They could be congenital or acquired and are usually associated with Hered-
itary Hemorrhagic Telengiectasia (70 %). They could be either single or multiple,
Central ( PA to LA Fistula ) or Peripheral ( PA to PV Fistula ). Usually they are
asymptomatic ( 30 – 55 % ) but sometimes they present with cyanosis, dyspnea on
exertion, neurological symptoms (migraine, vertigo, TIA, paresis, numbness, syncope,
confusion, cerebral abscess, seizures) or haemoptysis and haemo thorax. Diagnosis is
conﬁrmed by contrast (air bubble) echocardiography or CT / conventional angiog-
raphy. Pneumonectomy, lobectomy, local excision and ligation of the pulmonary
artery used to be the available treatment but carried a signiﬁcant morbidity and
mortality. Currently Endovascular Treatment is emerging as a promising alternative
and our series is perhaps the largest one.
Methods: The diagnosis is conﬁrmed by angiography, which is performed in many
views to delineate the point of communication. Long sheath is introduced and a
Berman catheter is then advanced via the long sheath and the balloon is inﬂated. The
large ﬂow across the BPF guides the balloon catheter to the branch supplying the BPF.
The Fistula is closed either by coil embolization ( Bioptome assisted ) or Amplatzer
ASD Device or Vascular Plug ( I , II , III ). The saturations (ideally PO2) usually
normalizes after complete occlusion.
Results: N : 28 AGE : 26 +/- 3.5 YRS CENTRAL : 3/28 PERIPHERAL : 25/28 COIL
EMBOLISATION ; 8 DEVICE CLOSURE : 23 ( in 3 pts add coils were used ) TECH
SUCCESS : 100% REPEAT PROCEDURE : 5/28 SpO2 Pre op : 70 +/- 2% SpO2
Post op : 95.4 +/- 3%.
Conclusions: Most of the massive Broncho Pulmonary Fistula can be managed by
endo vascular techniques and pneumectomy or any other major surgery can be
avoided. This series of 28 successfully treated cases of Central and Peripheral Broncho
Pulmonary AVM is probably one of the largest series.
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Background: We wanted to study the feasibility and safety of IVC ﬁlters retrieval in
patients with DVT with pulmonary thromboembolism (PTE) with IVC ﬁlter.
Methods: We retrospectively analyzed the data of patients who presented with DVT
with massive or sub-massive PTE and were treated with catheter thrombolysis and
IVC ﬁlter (Eclipse vena caval ﬁlter from Bard company) implantation in our unit in
the year 2012 -2013. CT pulmonary angiogram, venous colour Doppler and in some
cases MR venogram was done within 24 hrs before retrieval of ﬁlter. In conventional
contrast venogram, if the ﬁlter is patent and free from signiﬁcant clot burden (< 25%
ﬁlled with thrombus), removal is then performed. Success of retrieval was deﬁned
as complete and intact whole ﬁlter removal. Complications during the procedure
of retrieval like failure to remove the ﬁlter, distortion of the ﬁlter, migration of
ﬁlter, presence of thrombus in the ﬁlter, local puncture site hematomas were noted.
Results: A total of 32 patients of DVT with acute PTE and Retrieval IVC ﬁlters
implantations, were included in this study. Out of them 22 (68.75%) males andB152 JACC Vol 64/11/Suppl B j September 13–110 (31.25%) females with mean age of 46.2  12.6 years. In 15 patients(M:F::11:4)
retrieval was attempted after complete clearance of DVT and PTE with average time
period of 45 days (minimum - 25 days, maximum – one year). Successful retrieval
was done in 13 patients (86.7%).Failed to retrieve in two patients (13.3%) in whom
the implantation duration was one year. There were no distortion or migration of ﬁlter
or local puncture site hematoma were noted. In 11 patients (11 out of 13- 84.6%) there
was a small thrombus at the apex of the ﬁlter, which were conﬁrmed by histo-pa-
thology. No fatal complication like massive PTE or embolization of ﬁlter or IVC
rupture or tears were noted.
Conclusions: The success rate of retrieval of IVC ﬁlters were good (86.7%) beyond the
window period retrieval time coated by the company (15 to 21 days).Presence of small
thrombus from the retrieved ﬁlter is very high (84.6%) without any clinical events.
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Background: Popliteal Artery Aneurysms (PA) are traditionally treated surgically.
Endovascular procedures with implantation of stent grafts or covered stents have been
proposed as an alternative to surgery. Results are encouraging but some problems
remain (aneurysm rupture, endoleaks, collateral branch thrombosis.). We used a new
concept of stent, the Multilayer Flow Modulator (MFM*) to treat aneurysms and try to
avoid some drawbacks encountered with endografts.
Methods: This MFM* is a 3 Dimensional braided tube made of several inter-
connected layers without any covering. Our earliest tests in vitro (theorical simulation,
computerized Fluid dynamics, Molecular Modelization) and in vivo demonstrate that
this MFM* reduces the velocity in the aneurismal sac up to 90% by modifying the
hemodynamic conditions. A saccular aneurysm without collateral branch will
thrombose quickly. If a collateral branch is present the ﬂow is directed towards this
branch leading to shrinkage of the aneurysm. Animal experiments show excellent
results. Moreover, as demonstrated in animal and human studies this MFM* preserves
the collateral branches allowing the possibility to cover any artery without compro-
mising the ﬂow (renal, digestive arteries, supra aortic vessels .)
Results: 5 PA were treated with the MFM* (male: 5, mean age: 65 y.) 9 stents (Ø6 to
8 mm, length 40 to 120 mm) were implanted by percutaneous ipsilateral femoral
approach through 8F sheath. Technical success in all patients. All aneurysm throm-
bosed. Mid-term follow up will be presented. No stent fracture. This MFM* seems
well indicated for this popliteal location.
Conclusions: A new concept of stent, the MFM* is developed to treat aneurysm. It
opens a new approach to treat peripheral aneurysms avoiding most of the complica-
tions encountered with current endovascular techniques. The results obtained seem
promising. A larger study is ongoing.
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Background: Juvenile nasopharyngeal angioﬁbroma (JNA) or nasopharyngeal
angioﬁbroma is an uncommon ﬁbrovascular mass arising in the nasopharynx of
prepubertal and adolescent males. The tendency of the lesion for massive bleeding
leading to life threatening complications has led to its considerable importance in
medical fraternity. Preoperative biopsy is generally avoided for fear of massive
lethal bleeding. The condition is most commonly treated by surgical excision and
the surgical approach is chosen according to the disease stage. In view of their
hypervascular nature and propensity for massive bleeding Juvenile angioﬁbromas
may beneﬁt from preoperative devascularization to reduce intraoperative blood loss.
In our cases preoperative gel foam embolization was undertaken to reduce the
vascularity.
Methods: We present a case report of 6 cases which were admitted in the otor-
rhionology and surgery department with history of nasal breathing , nasal bleeding and
vertigo. Using 7F arterial sheath through transfemoral approach multipurpose cathter
(Asahi)was passed into the common carotid via the aorta. Selective injection was
made into the vessel which helped visualization of the angiﬁbroma. A 0.014 X 190
BMW (Abott)coronary guide wire was used to gain proximity to the root of the
angiosarcoma. A Stride Microcatheter was passed over the guide wire. Selective in-
jection through the microcatheter revealed the various branches of the angioﬁbroma.
Gel foam which was prepared externally was injected through the microcatheter into
the root of the angiosarcoma. Subsequent injections revealed gel embolization of the
feeding vessel rendering the area almost avascular. The patient was subsequently
taken up for the excision surgery within 2-3 days.
Results: Post surgery,blood supply retrieved in 5-6 days.
Conclusions: We conclude preoperative angiography is mandatory for identiﬁcation
of the feeding vessels in view of preoperative embolization before surgery in all cases
of JNA . The use of the appropriate guide wire , microcatheter and proper formation of
the gel solution is necessary for the successful attainment of avascular ﬁeld
preoperatively.7, 2014 j TCT Abstracts/Peripheral Vascular: Miscellaneous and Other
